---
document_datetime: 2023-09-21 18:54:39
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/teysuno-epar-all-authorised-presentations_en.pdf
document_name: teysuno-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.2130033
conversion_datetime: 2025-12-29 20:03:23.970011
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) Name   | Strength              | Pharmaceutical form   | Route of administration   | Immediate Packaging     | Pack size    |
|------------------|-------------------|-----------------------|-----------------------|---------------------------|-------------------------|--------------|
| EU/1/11/669/001  | Teysuno           | 15 mg/4.35 mg/11.8 mg | Capsule, hard         | Oral use                  | blister (PCTFE/PVC/alu) | 42 capsules  |
| EU/1/11/669/002  | Teysuno           | 15 mg/4.35 mg/11.8 mg | Capsule, hard         | Oral use                  | blister (PCTFE/PVC/alu) | 126 capsules |
| EU/1/11/669/003  | Teysuno           | 20 mg/5.8 mg/15.8 mg  | Capsule, hard         | Oral use                  | blister (PCTFE/PVC/alu) | 42 capsules  |
| EU/1/11/669/004  | Teysuno           | 20 mg/5.8 mg/15.8 mg  | Capsule, hard         | Oral use                  | blister (PCTFE/PVC/alu) | 84 capsules  |
| EU/1/11/669/005  | Teysuno           | 15 mg/4.35 mg/11.8 mg | Capsule, hard         | Oral use                  | blister (PCTFE/PVC/alu) | 84 capsules  |